Download presentation
Presentation is loading. Please wait.
Published byMarkus Kristoffersen Modified over 5 years ago
1
Outcome analysis of 245 CarboMedics and St
Outcome analysis of 245 CarboMedics and St. Jude valves implanted at the same institution Todd K Rosengart, MD, Maureen O’Hara, RN, Samuel J Lang, MD, Wilson Ko, MD, Nasser Altorki, MD, Karl H Krieger, MD, O.Wayne Isom, MD The Annals of Thoracic Surgery Volume 66, Issue 5, Pages (November 1998) DOI: /S (98)
2
Fig 1 Survival from all causes of death for patients with St. Jude valves (SJ) compared with CarboMedic valves (CM) at 1.5 years. The Annals of Thoracic Surgery , DOI: ( /S (98) )
3
Fig 2 Survival from valve-related death for patients with St. Jude valves (SJ) compared with CarboMedic valves (CM) at 1.5 years. The Annals of Thoracic Surgery , DOI: ( /S (98) )
4
Fig 3 (A) Survival from valve-related death for patients with St. Jude valves (SJ) compared with CarboMedic valves (CM) in isolated aortic valve replacement at 1.5 years. (B) Survival from valve-related death for patients with SJ compared with CM valves in isolated mitral valve replacement at 1.5 years. The Annals of Thoracic Surgery , DOI: ( /S (98) )
5
Fig 4 Freedom from a thromboembolic event in patients with St. Jude valves (SJ) compared with CarboMedic valves (CM) in isolated mitral valve replacement at 1.5 years. The Annals of Thoracic Surgery , DOI: ( /S (98) )
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.